Kimberly-Clark seeks EU approval for $40 billion Kenvue deal
28/08/2026 08:49
Kimberly-Clark seeks EU approval for $40 billion Kenvue deal Aug 28 (Reuters) - Kimberly-Clark KMB.O has asked EU regulators permission for its proposed $40 billion takeover of Tylenol maker Kenvue, documents on the EU Commission's website showed.
Kimberly-Clark announced the takeover in November last year.
The deal was expected to close in the second half of 2026, it said at the time.
Kimberly-Clark forecast $2.1 billion in annual cost savings from the deal.
The addition of Kenvue's vast portfolio of brands from Listerine mouth wash to skincare names like Aveeno and Neutrogena is expected to bring in annual revenues of roughly $32 billion for the combined company, it said.
(Reporting by Bart Meijer;
Editing by Sudip Kar-Gupta)
((Bart.Meijer@thomsonreuters.com;))